Manufacturer
NOVARTIS PHARMA STEIN AG
Contents
Deferasirox
Indication
Chronic iron overload.
Instruction
Should be taken on an empty stomach. Take at least 30 min before meals preferably at the same time daily
Drug interaction
May chelate Al when used w/ Al-containing antacids. Decreased exposure w/ colestyramine and potent inducers of UGT enzymes (e.g. carbamazepine, rifampicin, phenytoin). May increase serum concentration of CYP1A2 (e.g. duloxetine, theophylline) and CYP2C8 (e.g. repaglinide, paclitaxel) substrates, and decrease serum concentrations of CYP3A4 substrates (e.g. ciclosporin, hormonal contraceptives, simvastatin).
Malaysia
